Purine analogs: synthesis, evaluation and molecular dynamics of pyrazolopyrimidines based benzothiazole as anticancer and antimicrobial CDK inhibitors

References

• Rahmouni, A.; Souiei, S.; Belkacem, M. A.; Romdhane, A.; Bouajila, J.; Ben, J. H. Synthesis and Biological Evaluation of Novel Pyrazolopyrimidines Derivatives as Anticancer and Anti-5-Lipoxygenase Agents. Bioorg. Chem. 2016, 66, 160–168. DOI: 10.1016/j.bioorg.2016.05.001.
   PubMed Web of Science ®Google Scholar
• Shaaban, M. R.; Saleh, T. S.; Mayhoub, A. S.; Mansour, A.; Farag, A. M. Synthesis and Analgesic anti-Inflammatory Evaluation of Fused Heterocyclic Ring Systems Incorporating Phenylsulfonyl Moiety. Bioorg. Med. Chem. 2008, 16, 6344–6352. DOI: 10.1016/j.bmc.2008.05.011.
   PubMed Web of Science ®Google Scholar
• Shiota, T.; Yamamori, T.; Sakai, K.; Kiyokawa, M.; Honma, T.; Ogawa, M.; Hayashi, K.; Ishizuka, N.; Matsumura, K.; Hara, M.; et al. Synthesis and Structure –Activity Relationship of New Series of Potent Angiotensin II Receptor Antagonists: Pyrazolo[1,5-a] Pyrimidine Derivatives. Chem. Pharm. Bull. (Tokyo) 1999, 47, 928–938. DOI: 10.1248/cpb.47.928.
   PubMed Web of Science ®Google Scholar
• Modi, P.; Patel, S.; Chhabria, M. Structure-Based Design, Synthesis and Biological Evaluation of a Newer Series of Pyrazolo[1,5-a]Pyrimidine Analogues as Potential anti-Tubercular Agents. Bioorg. Chem. 2019, 87, 240–251. DOI: 10.1016/j.bioorg.2019.02.044.
   PubMed Web of Science ®Google Scholar
• Soares de Melo, C.; Feng, T.-S.; van der Westhuyzen, R.; Gessner, R. K.; Street, L. J.; Morgans, G. L.; Warner, D. F.; Moosa, A.; Naran, K.; Lawrence, N.; et al. Aminopyrazolo[1,5-a]Pyrimidines as Potential Inhibitors of mycobacterium tuberculosis : Structure Activity Relationships and ADME Characterization. Bioorg. Med. Chem. 2015, 23, 7240–7250. DOI: 10.1016/j.bmc.2015.10.021.
   PubMed Web of Science ®Google Scholar
• Petek, N.; Štefane, B.; Novinec, M.; Svete, J. Synthesis and Biological Evaluation of 7-(Aminoalkyl)Pyrazolo[1,5-a]Pyrimidine Derivatives as Cathepsin K Inhibitors. Bioorg. Chem. 2019, 84, 226–238. DOI: 10.1016/j.bioorg.2018.11.029.
   PubMed Web of Science ®Google Scholar
• Griffith, D. A.; Hargrove, D. M.; Maurer, T. S.; Blum, C. A.; De Lombaert, S.; Inthavongsay, J. K.; Klade, L. E.; Mack, C. M.; Rose, C. R.; Sanders, M. J.; Carpino, P. A. Discovery and Evaluation of Pyrazolo[1,5-a]Pyrimidines as Neuropeptide Y1 Receptor Antagonists. Bioorg. Med. Chem. Lett. 2011, 21, 2641–2645. DOI: 10.1016/j.bmcl.2010.12.116.
   PubMed Web of Science ®Google Scholar
• Elgemeie, G. H.; Helal, M. H.; El-Sayed, H. M. Synthesis of and Dyeing Characteristics of Novel Pyrazolo[1,5-a]-Pyrimidine Derivatives Containing Two Arylazo Functions. Pigment. Resin Technol. 2003, 32, 100–110. DOI: 10.1108/03699420310464801.
   Google Scholar
• Xu, J.; Liu, H.; Li, G.; He, Y.; Ding, R.; Wang, X.; Feng, M.; Zhang, S.; Chen, Y.; Li, S.; et al. 18F-Labeled Pyrazolo[1,5-a]Pyrimidine Derivatives: synthesis from 2,4-Dinitrobenzamide and Tosylate Precursors and Comparative Biological Evaluation for Tumor Imaging with Positron Emission Tomography. Molecules 2012, 17, 3774–3793. DOI: 10.3390/molecules17043774.
   PubMed Web of Science ®Google Scholar
• Bhullar, K. S.; Lagarón, N. O.; McGowan, E. M.; Parmar, I.; Jha, A.; Hubbard, B. P.; Rupasinghe, H. P. V. Kinase-Targeted Cancer Therapies: progress, Challenges and Future Directions. Mol. Cancer 2018, 17, 1–20.
   PubMed Web of Science ®Google Scholar
• Tadesse, S.; Caldon, E. C; Tilley, W.; Wang, S. Cyclin-Dependent Kinase 2 Inhibitors in Cancer Therapy: An Update. J. Med. Chem. 2018, 62, 4233–4251. DOI: 10.1021/acs.jmedchem.8b01469.
   PubMed Web of Science ®Google Scholar
• Krystof, V.; Baumli, S.; Furst, R. Perspective of Cylin-Dependent Kinase 9 (CDK9) as a Drug Target. CPD 2012, 18, 2883–2890. DOI: 10.2174/138161212800672750.
   Google Scholar
• Didier, R. The Impact of in Silico Screening in the Discovery of Novel and Safer Drug Candidates. Pharmacol. Ther. 2017, 175, 47–66.
   PubMed Web of Science ®Google Scholar
• Pattabiraman, K.; El-Khouri, R.; Modi, K.; McGee, L. R.; Chow, D. Synthesis of Novel Biaryl 2-Benzimidazoles and 2-Benzothiazoles. Tetrahedron Lett. 2009, 50, 1571–1574. DOI: 10.1016/j.tetlet.2009.01.085.
   Web of Science ®Google Scholar
• Azzam, R. A.; Osman, R. R.; Elgemeie, G. H. Efficient Synthesis and Docking Studies of Novel Benzothiazole-Based Pyrimidinesulfonamide Scaffolds as New Antiviral Agents and Hsp90α Inhibitors. ACS Omega. 2020, 5, 1640–1655. DOI: 10.1021/acsomega.9b03706.
   PubMed Web of Science ®Google Scholar
• Elgemeie, G. H.; Elghandour, A. H.; Elaziz, G. W. A. Novel cyanoketeneN,S-Acetals and Pyrazole Derivatives Using Potassium 2-Cyanoethylene-1-Thiolates. Synth. Commun. 2007, 37, 2827–2834. DOI: 10.1080/00397910701473317.
   Web of Science ®Google Scholar
• Elgemeie, G. H.; Elsayed, S. H.; Hassan, A. S. Direct Route to a New Class of Acrylamide Thioglycosides and Their Conversions to Pyrazole Derivatives. Synth. Commun. 2008, 38, 2700–2706. DOI: 10.1080/00397910802222605.
   Web of Science ®Google Scholar
• Fathy, N. M.; Motti, F. A.; Elgemeie, G. E. H. Nitriles in Heterocyclic Synthesis: novel Synthesis of Pyrido[2,1-b]Benzothiazoles and 1,3-Benzothiazole Derivatives. Arch. Pharm. Pharm. Med. Chem. 1988, 321, 509–512. DOI: 10.1002/ardp.19883210903.
   Web of Science ®Google Scholar
• Kurz, T.; Widyan, K.; Elgemeie, G. H. Novel Synthesis of Fluorinated cyanoketeneN,S-Acetals (IV) and Their Conversions to Fluorinated Pyrazole Derivatives. Phosphorus Sulfur Silicon Relat. Elem. 2006, 181, 299–304. DOI: 10.1080/104265090970368.
   Web of Science ®Google Scholar
• Elgemeie, G. H.; Elghandour, A. H.; Abd-Elaziz, G. W. Potassium 2-Cyanoethylene-1-Thiolate Derivative: A New Preparative Route to 2-Cyanoketene S,N-Acetals and Pyrazole Derivatives. Synth. Commun. 2004, 34, 3281–3291. DOI: 10.1081/SCC-200030549.
   Web of Science ®Google Scholar
• Elgemeie, G. H.; Zaghary, W. A.; Amin, K. M.; Nasr, T. M. A Direct Route to a New Class of Acrylamide Thioglycosides. J. Carbohydr. Chem. 2008, 27, 373–378. DOI: 10.1080/07328300802262786.
   Web of Science ®Google Scholar
• Elgemeie, G. H.; Jones, P. G. 5-Amino-3-anilino-N-(Chlorophenyl)-1H-Pyrazole-4-Carboxamide Ethanol Solvent. Acta. Cryst. 2004, E60, 1616–1618.
   Google Scholar
• Azevedo, W. F.; Leclerc, S.; Meijer, L.; Havlicek, L.; Strnad, M.; Kim, S. H. Inhibition of Cyclin-Dependent Kinases by Purine Analogues. Crystal Structure of Human cdk2 Complexed with Roscovitine. Eur. J. Biochem. 1997, 243, 518–526. DOI: 10.1111/j.1432-1033.1997.0518a.x.
   PubMedGoogle Scholar
• Baumli, S.; Lolli, G.; Lowe, E. D.; Troiani, S.; Rusconi, L.; Bullock, A. N.; Debreczeni, J. É.; Knapp, S.; Johnson, L. N. The Structure of P-TEFb (cdk9/Cyclin T1), Its Complex with Flavopiridol and Regulation by Phosphorylation. Embo J. 2008, 27, 1907–1918. DOI: 10.1038/emboj.2008.121.
   PubMed Web of Science ®Google Scholar
• Molecular Operating Environment (MOE). 2016.08; Chemical Computing Group Inc., 1010 Sherbrooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7, 2016.
   Google Scholar
• https://dtp.cancer.gov/discovery_development/nci-60/methodology.htm.
   Google Scholar
• Zegzouti, H.; Vidugiriene, J.; Goueli, S. A. Ph.D Ph.D Ph.D., Promega Corporation, 2011.
   Google Scholar
• BPS Bioscience. 6042 Cornerstone Court W, Ste B San Diego, CA 92121, 2018.
   Google Scholar
• Scott, A. C. Laboratory Control of Antimicrobial Therapy. In Practical Medical Microbiology, Collee, J. G. eds. 13th ed. Churchill Livingstone, UK: Edinburgh, 1989; p. 161
   Google Scholar
• Wiegand, I.; Hilpert, K.; Robert, E. W. H. Agar and Broth Dilution Methods to Determine the Minimal Inhibitory Concentration (MIC) of Antimicrobial Substances. Nat. Protoc. 2008, 3, 163–175. DOI: 10.1038/nprot.2007.521.
   PubMed Web of Science ®Google Scholar
• Dawood, K. M.; Kandeel, Z. E.; Farag, A. M. Heterocyclic Synthesis via Enaminonitriles: A Convenient Route to Some New Pyrazole, Isoxazole, Pyrimidine, Pyrazolo [1,5-a] Pyrimidine, Pyrimido [1,2-a] Benzimidazole and Pyrido [1,2-a] Benzimidazole Derivatives. J. Chem. Res. 1998, 4, 208–209. DOI: 10.1039/a707362c.
   Google Scholar
• Azzam, R. A.; Elgemeie, G. H.; Osman, R. R. Synthesis of Novel Pyrido [2,1-b] Benzothiazole and N-Substituted 2-Pyridylbenzothiazole Derivatives Showing Remarkable Fluorescence and Biological Activities. J. Mol. Struct. 2020, 1201, 127–194.
   Web of Science ®Google Scholar
• Azzem, M. A.; Elgemeie, G. E.; Neguid, M. A.; Fahmy, H. M.; Elmassry, Z. M. Electro-Organic Synthesis of Some Cyclopentanone Derivatives. J. Chem. Soc. 1990, 2, 545–550.
   Google Scholar
• Azzam, R. A.; Elsayed, R. E.; Elgemeie, G. H. Novel Synthesis and Antiviral Evaluation of New Benzothiazole-Bearing N-Sulfonamide 2-Pyridone Derivatives as USP7 Enzyme Inhibitors. ACS Omega 2020, 5, 26182–26194. DOI: 10.1021/acsomega.0c03773.
   PubMed Web of Science ®Google Scholar
• Krystof, V.; Uldrijan, S. Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs. Curr. Drug Targets 2010, 11, 291–302. DOI: 10.2174/138945010790711950.
   PubMed Web of Science ®Google Scholar
• Zhang, H.; Khalil, Z.; Conte, M.; M; Plisson, F.; Capon, R. J. A Search for Kinase Inhibitors and Antibacterial Agents: bromopyrrolo-2-Aminoimidazoles from a Deep-Water Great Australian Bight Sponge, Axinella sp. Tetrahedron Lett. 2012, 53, 3784–3787. DOI: 10.1016/j.tetlet.2012.05.051.
   Web of Science ®Google Scholar
• Cicenas, J.; Kalyan, K.; Sorokinas, A.; Jatulyte, A.; Valiunas, D.; Kaupinis, A.; Valius, M. Highlights of the Latest Advances in Research on Cdk Inhibitors. Cancers 2014, 6, 2224–2242. DOI: 10.3390/cancers6042224.
   PubMed Web of Science ®Google Scholar
• Kim, J. N.; Blount, K. F.; Puskarz, I.; Lim, J.; Link, K. H.; Breaker, R. R. Design and Antimicrobial Action of Purine Analogues That Bind Guanine Riboswitches. ACS Chem. Biol. 2009, 4, 915–927. DOI: 10.1021/cb900146k.
   PubMed Web of Science ®Google Scholar